Anti-VEGF Innovations in Retinal Disease Emerging anti-VEGF agents offer enhanced durability and anatomic outcomes in retinal disease. A recent Ophthalmology Times Case-Based Roundt…
From Pilot to Practice: Implementing Photobiomodulation for Dry AMD Dry age-related macular degeneration progresses in quiet increments, r…
Hong Kong's Securities Watchdog Eyes IPO Reform Hong Kong's market regulator is reviewing rules to potentially allow smaller but high-pote…
PayChangu Dominates at the 2025 Standard Bank and SMEDI Phuka SME Awards PayChangu, a leading fintech company in Malawi, emerged as the st…
Hong Kong Tennis Open: Last China Players Exit China's last two representatives, Zhang Shuai and Wang Yafan, lost in straight sets at the …
AGCO Power Unveils Next-Generation Sustainable Powertrain Innovations At Agritechnica 2025 in Hanover, AGCO Power will unveil a bold visio…
Wizz Air Revives $580 Pass and Tests Business Class Wizz Air brings back its $580 'All You Can Fly' deal and begins testing a new business…
Exercise and Heart Risk: A New Study Reveals Key Differences Between Men and Women According to a recent study, men need almost twice as m…
Everest Medicines Acquires Exclusive Rights to VIS-101 for Serious Eye Disorders Everest Medicines announced an exclusive license with Vis…
Transparent Squid for Brain Research Researchers at the Marine Biological Laboratory (MBL) in Woods Hole, Massachusetts, have successfully…
A Time for Burning: A Timeless Look at Racial Reconciliation The documentary "A Time for Burning" offered an honest look at race in 1960s …